In 2014, the new state leadership developed antibiotics management measures for the Ministry of Health and strengthened the management of drug resistance mutation of clinical pathogenic microorganisms. As a result, problems like restrictions on medical insurance and puzzling of patients are better solved.

Interpret related policies, promote the rational use of antibiotics, reduce inappropriate management approaches of hospitals, and improve the status and level of pharmacies in antibiotics management, so as to play an important role in enhancing and promoting the scientific and refined management of clinical use of antibiotics.

Related leaders involved in national antibiotics management, hospital managements, pharmacies and famous experts in anti-infection and other fields

The classified management approach is scientific and in line with the realities of China.
The effective implementation of classified management involves: 1. prescription permissions, 2. expert consultation, 3. skip-level use. 4. approval mechanism
DDD cannot be treated in a mechanistic fashion, but it should center on patients and make rational use of antibiotics, and should make overall consideration of odds ratio (OR) and numbers needed to treat (NNT) which determine the use of antibiotics. Meanwhile, attention should be paid to drug control and infection control.

Gather related leaders involved in national antibiotics management, hospital managements, pharmacies and famous experts in anti-infection and other fields to discuss how to understand the new policies and help Chinese medical institutions at all levels to develop more appropriate, scientific and refined hospital managements measures under new policy environment. Besides, warm discussions were made with the experts present to combine the experience from the hospital with that of other hospitals and promote the progress of rational antibiotics use in China.

Gather related leaders involved in national antibiotics management, hospital managements, pharmacies and famous experts in anti-infection and other fields to discuss how to understand the new policies and help Chinese medical institutions at all levels to develop more appropriate, scientific and refined hospital managements measures under new policy environment. Besides, warm discussions were made with the experts present to combine the experience from the hospital with that of other hospitals and promote the progress of rational antibiotics use in China.